We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

9 hedge funds and large institutions have $90.2K invested in Quoin Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.48% less ownership

Funds ownership: 0.54% → 0.06% (-0.48%)

31% less funds holding

Funds holding: 13 → 9 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

91% less capital invested

Capital invested by funds: $1.01M → $90.2K (-$916K)

Holders
9
Holders Change
-4
Holders Change %
-30.77%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$80.6K
2
Lido Advisors
Lido Advisors
California
+$8.84K
3
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$6.63K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.21K
5
Morgan Stanley
Morgan Stanley
New York
+$171

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$345K
2
ACM
Altium Capital Management
New York
-$184K
3
IC
Ikarian Capital
Texas
-$179K
4
Renaissance Technologies
Renaissance Technologies
New York
-$86.6K
5
BFM
Boothbay Fund Management
New York
-$52.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$49.1K +$80.6K +6,130 +4,507%
AWM
2
Apollon Wealth Management
South Carolina
$17.9K – – –
RhumbLine Advisers
3
RhumbLine Advisers
Massachusetts
$9.55K +$6.63K +504 +73%
Raymond James Financial
4
Raymond James Financial
Florida
$5.62K – – –
Lido Advisors
5
Lido Advisors
California
$5.26K +$8.84K +672 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$2.57K +$4.21K +320 New
Morgan Stanley
7
Morgan Stanley
New York
$102 +$171 +13 New
JP Morgan Chase
8
JP Morgan Chase
New York
$33 +$53 +4 New
SS
9
SBI Securities
Japan
$24 +$26 +2 +200%
HNB
10
Huntington National Bank
Ohio
$6 – – –
RBI
11
Raiffeisen Bank International
Austria
$4 – – –
AC
12
Armistice Capital
New York
– -$345K -15,143 Closed
ACM
13
Altium Capital Management
New York
– -$184K -8,064 Closed
IC
14
Ikarian Capital
Texas
– -$179K -7,857 Closed
Renaissance Technologies
15
Renaissance Technologies
New York
– -$86.6K -3,803 Closed
BFM
16
Boothbay Fund Management
New York
– -$52.5K -2,306 Closed
TSS
17
Two Sigma Securities
New York
– -$34.2K -1,501 Closed
XT
18
XTX Topco
Cayman Islands
– -$20.2K -887 Closed
HF
19
HRT Financial
New York
– -$18K -792 Closed

QNRX Hedge Fund Activity: Q1 2025 in Review

9 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q1 2025, worth a combined $90.2K — down 91% from $1.01M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of QNRX and 4 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was UBS Group, adding an estimated $80.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $345K sold.

  • 9 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q1 2025, down from 13 in Q4 2024.
  • Funds reported $90.2K of Quoin Pharmaceuticals stock for Q1 2025, down 91% quarter-over-quarter.
  • 4 funds opened new Quoin Pharmaceuticals positions in Q1 2025 and 8 closed out, a net change of -4 holders.
  • The largest Quoin Pharmaceuticals buyer in Q1 2025 was UBS Group, an estimated $80.6K added.
  • The largest Quoin Pharmaceuticals seller in Q1 2025 was Armistice Capital, an estimated $345K sold.

Based on aggregated 13F filings for Q1 2025.